Literature DB >> 2672771

On-grid immunogold labeling of glial intermediate filaments in epoxy-embedded tissue.

A B Johnson1, A Bettica.   

Abstract

On-grid immunogold labeling of structures like intermediate filaments has been difficult to achieve. Presumably this is because such structures are thinner than the thin sections themselves and because gold-labeled reagents remain on the surface and do not penetrate epoxy resins. Many pathologic and other tissues, however, are primarily available as epoxy-embedded blocks, and a postembedding gold procedure capable of detecting such thin structures would be useful. This study aimed to investigate the astrocytic intermediate filament antigen glial fibrillary acidic protein (GFAP) in glutaraldehyde-fixed, epoxy-embedded brain biopsy tissue from a child with Alexander's disease. A protocol was developed for performing on-grid immunogold labeling which minimized nonspecific deposition of gold reagent. The method utilized ovalbumin and skim milk in the washes and diluent for the gold reagent and the same solution with added Tween-20 and high sodium chloride in the diluent for antibodies and normal serum. In grids etched with metaperiodate and hydrogen peroxide, the astrocytic intermediate filaments were only occasionally and sparsely labeled. When an etching procedure with sodium ethoxide was employed, however, extensive labeling was obtained on the astrocytic intermediate filaments. In contrast, the larger, pathological Rosenthal fibers characteristic of Alexander's disease were labeled after both etching procedures, but labeling was enhanced after ethoxide etching. Postosmicated material showed much less labeling. The findings demonstrate that postembedding procedures can be used with epoxy-embedded material to immunolabel thin structures like intermediate filaments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672771     DOI: 10.1002/aja.1001850228

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


  15 in total

1.  Rosenthal fibers contain ubiquitinated alpha B-crystallin.

Authors:  J E Goldman; E Corbin
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

Review 2.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

3.  Alpha B-crystallin is associated with intermediate filaments in astrocytoma cells.

Authors:  T Wisniewski; J E Goldman
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.

Authors:  Ming Der Perng; Mu Su; Shu Fang Wen; Rong Li; Terry Gibbon; Alan R Prescott; Michael Brenner; Roy A Quinlan
Journal:  Am J Hum Genet       Date:  2006-06-12       Impact factor: 11.025

5.  Formation of crystalloid inclusions in the small intestine of neonatal pigs: an immunocytochemical study using colloidal gold.

Authors:  L G Kömüves; B L Nicols; T W Hutchens; J P Heath
Journal:  Histochem J       Date:  1993-01

6.  The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells.

Authors:  Tomokatsu Yoshida; Yasuko Tomozawa; Takayo Arisato; Yuji Okamoto; Hirofumi Hirano; Masanori Nakagawa
Journal:  J Hum Genet       Date:  2007-02-22       Impact factor: 3.172

7.  GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.

Authors:  Li Li; E Tian; Xianwei Chen; Jianfei Chao; Jeremy Klein; Qiuhao Qu; Guihua Sun; Guoqiang Sun; Yanzhou Huang; Charles D Warden; Peng Ye; Lizhao Feng; Xinqiang Li; Qi Cui; Abdullah Sultan; Panagiotis Douvaras; Valentina Fossati; Neville E Sanjana; Arthur D Riggs; Yanhong Shi
Journal:  Cell Stem Cell       Date:  2018-08-02       Impact factor: 24.633

8.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

9.  Immunoelectron microscopy of Rosenthal fibers.

Authors:  B Lach; M Sikorska; P Rippstein; A Gregor; W Staines; T R Davie
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Alexander disease: a leukodystrophy caused by a mutation in GFAP.

Authors:  Anne B Johnson
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.